The new antidiabetic drug MCC-555 ameliorates insulin resistance and acutely sensitizes insulin signaling by activation of protein synthesis

Jurgen Eckel, TANAKA Hideho, ISHII ShinichiLisen Liu, Hideho Tanaka

    Research output: Contribution to journalArticle

    Original languageEnglish
    JournalDefault journal
    Publication statusPublished - 1998 Jun 13

    Cite this